跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gliptanova-50 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gliptanova-50
Approved
STANDARD
Gliptanova-50
Eskayef Pharmaceuticals Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7966283c29bfd8c3
Company
Eskayef Pharmaceuticals Limited
Type
Standard
Approval Details
Approval Id
7966283c29bfd8c3
Drug Approval Philippines Name
Gliptanova-50
Product Name
Gliptanova-50
Registration Number
DRP-16383
Brand Name
Gliptanova-50
Generic Name
Sitagliptin (as phosphate monohydrate)
Dosage Form
Film Coated Tablets
Dosage Strength
50 mg
Manufacturer
Eskayef Pharmaceuticals Limited
Company Detail Path
/organization/eskayef-pharmaceuticals-limited
Issuance Date
28 February 2025
Expiry Date
28 February 2030
Pharmacologic Category
Dipeptidyl peptidase 4 (DDP-4) Inhibitor
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7966283c29bfd8c3
Type
Standard
Back to Philippines FDA Approvals